#VisualAbstract: Addition of Denosumab to Neoadjuvant Paclitaxel Does Not Improve Complete Response Rate in Breast Cancer
Click to read this study in JAMA Oncology.
Read MoreAug 10, 2022
Click to read this study in JAMA Oncology.
Read MoreAug 10, 2022
Click here to read this study in NEJM.
Read MoreAug 5, 2022
1. Fewer patients in the thrombectomy group achieved an MRS score of 0-2 at 90 days compared to...
Read MoreAug 5, 2022
Click to read this study in The Lancet Oncology.
Read MoreAug 5, 2022
Click here to read this study in NEJM.
Read MoreAug 5, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreAug 5, 2022
1. No significant differences in treatment success and rate of adverse events were detected in 8...
Read MoreAug 5, 2022
Click to read this study in JAMA.
Read MoreJul 31, 2022
Click to read this study in JAMA.
Read MoreJul 28, 2022
Click to read this study in JAMA.
Read MoreJul 28, 2022
Click to read this study in JAMA.
Read MoreJul 28, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreJul 22, 2022
Click to read this study in JAMA
Read MoreJul 21, 2022
Click to read this study in JAMA.
Read MoreJul 21, 2022
Click to read this study in JAMA.
Read MoreJul 21, 2022
Click to read this study in JAMA Network Open.
Read MoreJul 21, 2022
Click to read this study in JAMA Oncology.
Read MoreJul 8, 2022
1. In patients with sepsis receiving a vasopressor in the intensive care unit (ICU), intravenous...
Read MoreJul 8, 2022
Click here to read this study in the New England Journal of Medicine.
Read MoreJul 8, 2022
Click to read this study in the New England Journal of Medicine.
Read More